Diana Bilton

Summary

Publications

  1. ncbi request reprint Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
    Diana Bilton
    Papworth Hospital, Adult CF Centre, Papworth Everard Cambridge, Cambridge CB38RE, UK
    Chest 130:1503-10. 2006
  2. ncbi request reprint End of life care for adult cystic fibrosis patients: facilitating a good enough death
    Elizabeth Chapman
    Adult Cystic Fibrosis Centre, Papworth NHS Trust, Papworth Everard, Cambridge CB3 8RE United Kingdom
    J Cyst Fibros 4:249-57. 2005
  3. ncbi request reprint Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis
    S Lorraine Martin
    School of Pharmacy, Queen s University Belfast, Belfast, Northern Ireland, UK
    Pediatr Pulmonol 41:177-83. 2006
  4. ncbi request reprint Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis
    Elizabeth F Shead
    Department of Haematology, NHS Foundation Trust, Addenbrooke s Hospital, Cambridge, United Kingdom
    Am J Respir Crit Care Med 174:306-11. 2006
  5. pmc Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults
    Amanda I Adler
    Addenbrooke s Hospital, Cambridge, UK
    Diabetes Care 31:1789-94. 2008
  6. pmc What did we learn from the North American Cystic Fibrosis Conference?
    Diana Bilton
    Department of Respiratory Medicine, Royal Brompton Hospital Sydney Street, London SW3 6NP, UK
    J R Soc Med 101:S6-9. 2008

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis
    Diana Bilton
    Papworth Hospital, Adult CF Centre, Papworth Everard Cambridge, Cambridge CB38RE, UK
    Chest 130:1503-10. 2006
    ....
  2. ncbi request reprint End of life care for adult cystic fibrosis patients: facilitating a good enough death
    Elizabeth Chapman
    Adult Cystic Fibrosis Centre, Papworth NHS Trust, Papworth Everard, Cambridge CB3 8RE United Kingdom
    J Cyst Fibros 4:249-57. 2005
    ..This study examined how a number of recent deaths have been handled in an adult CF centre in the UK...
  3. ncbi request reprint Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis
    S Lorraine Martin
    School of Pharmacy, Queen s University Belfast, Belfast, Northern Ireland, UK
    Pediatr Pulmonol 41:177-83. 2006
    ..This study demonstrated that nebulized rAAT is safe and well-tolerated, but has a limited effect on NE activity and other markers of inflammation...
  4. ncbi request reprint Osteoclastogenesis during infective exacerbations in patients with cystic fibrosis
    Elizabeth F Shead
    Department of Haematology, NHS Foundation Trust, Addenbrooke s Hospital, Cambridge, United Kingdom
    Am J Respir Crit Care Med 174:306-11. 2006
    ..Adults with cystic fibrosis (CF) are at increased risk of developing osteoporosis. During infective exacerbations, increased production of proinflammatory cytokines and markers of bone resorption have been reported...
  5. pmc Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults
    Amanda I Adler
    Addenbrooke s Hospital, Cambridge, UK
    Diabetes Care 31:1789-94. 2008
    ..In this study we documented the incidence of CFRD and evaluated the association between mutations responsible for cystic fibrosis and incident CFRD, while identifying potential risk factors...
  6. pmc What did we learn from the North American Cystic Fibrosis Conference?
    Diana Bilton
    Department of Respiratory Medicine, Royal Brompton Hospital Sydney Street, London SW3 6NP, UK
    J R Soc Med 101:S6-9. 2008